Use of urokinase in acute myocardial infarction.
In a prospective study 88 patients with acute MI were treated with urokinase. In comparison to a control group without thrombolytic therapy 50% of the urokinase treated patients showed an improvement as well of coronary sinus blood flow as of parameters of QRST mapping.
Makolkin
V I
VI
First Medical Institute (Setchenow), Moscow, USSR.
Bokarew
I N
IN
Buturow
V N
VN
Terechow
V N
VN
Kuznetzow
V A
VA
Seryogina
M V
MV
Yarowaya
L D
LD
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D011446:Prospective Studies; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D014568:Urokinase-Type Plasminogen Activator